Carnegie Mellon University, the University of Pittsburgh and UPMC have joined forces to create the Pittsburgh Health Data Alliance, a powerful collaboration to transform big data in healthcare and wellness. This one-of-a-kind alliance is a wide-reaching commitment to advance technology and create new data-heavy health care innovations over the coming years, resulting in spin-off companies and furthering economic development in the region.
Today’s health care system generates massive amounts of data –patient information in the electronic health record, diagnostic imaging, prescriptions, genomic profiles, insurance records, even data from wearable devices. Information has always been essential for guiding the care of individuals, but computer tools now make it possible to use that data to provide deeper insights into disease itself.
For example, the use of smart data could help hospitals and doctors rapidly detect potential new outbreaks and immediately alert staff and authorities to take appropriate actions. Systems based around this principle of finding emerging events in complex data sets have already been made possible by collaborations among UPMC, Pitt, and CMU.
Pittsburgh Health Data Alliance Overview
The alliance, funded by UPMC, will see its work carried out by Pitt-led and CMU-led centers, with participation from all three institutions. The centers will work to transform the explosion of health-related data into new technologies, products and services to change the way diseases are prevented and how patients are diagnosed, treated and engaged in their own care.
Using health care data to its full potential will require close collaboration among the leading health sciences research at Pitt, world-class computer science and machine learning at CMU, and the clinical care, extensive patient data and commercialization expertise at UPMC. The close proximity among these organizations in Pittsburgh provide the ideal setting to transform all aspects of health care, not only in western Pennsylvania but around the world.
New Research Centers
The new research centers at CMU and Pitt will be funded over the next six years by UPMC and also will benefit from several hundred million dollars in existing research grants at all three institutions. They promise to create what UPMC CEO Jeffrey Romoff calls an “innovation ecosystem” for health data in the region.
The alliance will support applied research and commercialization, along with basic foundational research in medicine and computer science. Initially, the Pittsburgh Health Data Alliance will include two research and development centers: the Center for Machine Learning and Health (CMLH), led by founding director Eric Xing, Ph.D., a CMU professor in the Department of Machine Learning; and the Center for Commercial Applications of Healthcare Data (CCA), spearheaded by Michael Becich, M.D., Ph.D., chair of the Department of Biomedical Informatics at Pitt. Scientists from all three institutions will participate in the work of each center.
CMLH Research Focus
The CMLH will work on challenging problems at the intersections of health care and machine learning. Data from sources as varied as electronic medical records, genomic sequencing, insurance records and wearable sensors will be utilized to directly improve health care. For example, imagine a smartphone app that suggests the single dietary change that will most improve your health, based on your genetic makeup and medical history. Or suppose a physician receives an automatic alert when a patient enters the earliest stages of rejecting a transplanted organ and can react while the condition is most easily treatable. The center will focus on five areas: big health care data analytics; personalized medicine and disease modeling; issues of privacy, security and compliance in the context of big data; data-driven patient and provider education and training; and a new general framework for big data in health care.
CCA at the University of Pittsburgh Research Focus
The CCA at the University of Pittsburgh will research and invent new technology for potential use in commercial theranostics and imaging systems for patients and doctors. (Theranostics works to develop individualized therapies for various diseases, and to combine diagnostic and therapeutic capabilities.) These technologies will be based on intelligently engineered big data solutions. Some areas of focus for CCA will be: personalized medicine for understanding diseases such as cancer and various lung disorders; genomics and imaging data; and methods for data capture and health care analytics. A key goal is new technologies and methods to create actionable information.
UPMC Enterprises, the commercialization arm of UPMC, will lead the efforts to turn these innovative ideas into new, for-profit companies and jobs, building on its nearly 20-year track record of investing in and growing companies that solve health care problems.
For more information about the Pittsburgh Health Data Alliance, visit www.healthdataalliance.com.
